Nifty
:
22147.00
Sensex
:
73088.33
151.15 (0.69%)
599.34 (0.83%)
Nifty
Sensex
:
:
22147.00
73088.33
151.15 (0.69%)
599.34 (0.83%)

Titan Bio-Tech Ltd.

Chemicals

Rating :
60/99

BSE: 524717 | NSE: Not Listed

NSE BSE
500.85
19-Apr-2024
  • Open
  • High
  • Low
  • Previous Close
  •  490.50
  •  514.45
  •  485.00
  •  496.05
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  347
  •  70.22
  •  618.00
  •  228.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 413.89
  • 16.68
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 416.57
  • 0.36%
  • 3.22

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 55.88%
  • 1.66%
  • 30.06%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 12.40%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.92
  • 17.28
  • 0.41

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 24.96
  • 27.07
  • -8.56

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 30.30
  • 42.96
  • -11.51

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.32
  • 8.71
  • 9.32

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.05
  • 2.27
  • 2.74

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.20
  • 6.46
  • 7.40

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
45.98
30.33
51.60%
43.43
41.83
3.83%
34.75
35.00
-0.71%
36.84
32.94
11.84%
Expenses
35.38
26.20
35.04%
34.71
31.35
10.72%
26.86
26.93
-0.26%
30.01
25.51
17.64%
EBITDA
10.60
4.14
156.04%
8.71
10.48
-16.89%
7.89
8.07
-2.23%
6.83
7.42
-7.95%
EBIDTM
23.06%
13.65%
20.06%
25.05%
22.70%
23.05%
18.54%
22.53%
Other Income
0.44
0.28
57.14%
0.55
0.86
-36.05%
0.28
0.32
-12.50%
0.49
0.39
25.64%
Interest
0.26
0.14
85.71%
0.28
0.17
64.71%
0.29
0.18
61.11%
0.26
0.20
30.00%
Depreciation
0.84
0.65
29.23%
0.86
0.64
34.38%
0.80
0.61
31.15%
0.71
0.71
0.00%
PBT
9.94
3.63
173.83%
8.13
10.53
-22.79%
7.09
7.60
-6.71%
6.35
6.91
-8.10%
Tax
2.56
0.93
175.27%
2.10
2.63
-20.15%
1.68
1.83
-8.20%
1.71
1.76
-2.84%
PAT
7.38
2.70
173.33%
6.03
7.90
-23.67%
5.41
5.78
-6.40%
4.64
5.15
-9.90%
PATM
16.06%
8.90%
13.88%
18.89%
15.57%
16.51%
12.60%
15.64%
EPS
8.68
3.95
119.75%
7.89
11.04
-28.53%
7.46
9.08
-17.84%
5.99
6.03
-0.66%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
161.00
144.00
123.55
142.24
79.44
64.91
57.37
52.74
45.77
40.32
Net Sales Growth
14.92%
16.55%
-13.14%
79.05%
22.38%
13.14%
8.78%
15.23%
13.52%
 
Cost Of Goods Sold
74.70
69.79
57.56
59.88
39.35
32.70
31.77
32.85
29.62
25.24
Gross Profit
86.30
74.21
66.00
82.36
40.09
32.21
25.60
19.89
16.16
15.08
GP Margin
53.60%
51.53%
53.42%
57.90%
50.47%
49.62%
44.62%
37.71%
35.31%
37.40%
Total Expenditure
126.96
114.48
92.28
96.05
65.95
56.00
50.39
47.37
41.86
36.43
Power & Fuel Cost
-
8.98
6.67
4.19
3.59
3.25
3.19
2.09
1.84
2.12
% Of Sales
-
6.24%
5.40%
2.95%
4.52%
5.01%
5.56%
3.96%
4.02%
5.26%
Employee Cost
-
18.21
14.24
13.09
11.51
9.43
6.61
2.89
3.45
2.73
% Of Sales
-
12.65%
11.53%
9.20%
14.49%
14.53%
11.52%
5.48%
7.54%
6.77%
Manufacturing Exp.
-
7.15
6.57
11.61
5.09
4.72
3.73
5.37
2.96
2.86
% Of Sales
-
4.97%
5.32%
8.16%
6.41%
7.27%
6.50%
10.18%
6.47%
7.09%
General & Admin Exp.
-
3.44
2.28
2.56
3.76
3.96
3.13
2.25
2.02
1.79
% Of Sales
-
2.39%
1.85%
1.80%
4.73%
6.10%
5.46%
4.27%
4.41%
4.44%
Selling & Distn. Exp.
-
6.21
4.61
4.00
2.48
1.58
1.84
1.76
1.88
1.53
% Of Sales
-
4.31%
3.73%
2.81%
3.12%
2.43%
3.21%
3.34%
4.11%
3.79%
Miscellaneous Exp.
-
0.71
0.34
0.72
0.17
0.37
0.12
0.16
0.10
0.15
% Of Sales
-
0.49%
0.28%
0.51%
0.21%
0.57%
0.21%
0.30%
0.22%
0.37%
EBITDA
34.03
29.52
31.27
46.19
13.49
8.91
6.98
5.37
3.91
3.89
EBITDA Margin
21.14%
20.50%
25.31%
32.47%
16.98%
13.73%
12.17%
10.18%
8.54%
9.65%
Other Income
1.76
1.94
0.94
0.79
0.45
0.69
0.45
0.28
0.55
0.40
Interest
1.09
0.75
0.87
1.73
2.35
2.34
2.39
1.48
1.03
0.99
Depreciation
3.21
2.60
2.37
2.22
1.80
1.71
0.93
0.82
0.77
0.84
PBT
31.51
28.12
28.97
43.03
9.79
5.54
4.10
3.35
2.65
2.45
Tax
8.05
7.09
7.28
11.00
2.57
1.63
1.43
1.17
0.88
0.82
Tax Rate
25.55%
25.21%
25.13%
25.76%
24.71%
29.42%
34.88%
34.93%
33.21%
33.47%
PAT
23.46
21.02
21.68
30.34
7.07
3.52
2.55
2.18
1.77
1.63
PAT before Minority Interest
23.46
21.02
21.68
31.71
7.84
3.91
2.67
2.18
1.77
1.63
Minority Interest
0.00
0.00
0.00
-1.37
-0.77
-0.39
-0.12
0.00
0.00
0.00
PAT Margin
14.57%
14.60%
17.55%
21.33%
8.90%
5.42%
4.44%
4.13%
3.87%
4.04%
PAT Growth
8.96%
-3.04%
-28.54%
329.14%
100.85%
38.04%
16.97%
23.16%
8.59%
 
EPS
28.27
25.33
26.12
36.55
8.52
4.24
3.07
2.63
2.13
1.96

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
109.91
86.24
68.76
39.19
32.18
24.36
23.01
21.53
20.47
Share Capital
8.26
8.26
8.26
8.26
8.26
7.74
7.74
7.74
7.74
Total Reserves
101.65
77.98
60.49
30.93
23.91
16.62
15.27
13.79
12.73
Non-Current Liabilities
4.25
4.90
8.96
14.06
15.19
20.25
15.79
4.74
2.56
Secured Loans
0.30
1.08
2.24
2.60
3.22
4.02
3.62
0.33
0.59
Unsecured Loans
0.00
0.00
2.62
8.96
9.95
13.85
11.56
3.95
1.60
Long Term Provisions
1.62
1.43
1.32
1.28
0.98
1.62
0.00
0.00
0.00
Current Liabilities
27.54
23.99
29.78
22.44
16.97
12.09
12.25
12.66
10.47
Trade Payables
5.55
4.16
3.71
4.12
2.14
1.09
1.40
1.71
1.42
Other Current Liabilities
8.91
7.47
6.75
4.58
3.78
2.82
1.86
2.34
2.12
Short Term Borrowings
5.53
4.72
8.29
11.34
9.68
7.10
7.28
7.13
5.52
Short Term Provisions
7.55
7.64
11.03
2.39
1.37
1.08
1.71
1.48
1.42
Total Liabilities
141.70
115.13
111.22
78.04
65.92
57.89
52.18
40.06
33.50
Net Block
35.89
34.99
33.61
31.16
29.02
13.68
12.85
11.27
10.83
Gross Block
52.46
48.97
45.51
40.85
36.90
21.74
19.98
17.58
16.37
Accumulated Depreciation
16.57
13.98
11.90
9.69
7.89
8.06
7.13
6.32
5.54
Non Current Assets
66.21
44.34
41.89
31.84
29.59
27.53
22.63
16.26
12.25
Capital Work in Progress
13.29
3.63
0.27
0.07
0.00
13.31
9.32
4.55
1.14
Non Current Investment
15.41
4.03
0.00
0.00
0.00
0.00
0.00
0.00
0.05
Long Term Loans & Adv.
1.35
1.52
7.83
0.61
0.57
0.54
0.47
0.41
0.18
Other Non Current Assets
0.26
0.16
0.18
0.00
0.00
0.00
0.00
0.04
0.04
Current Assets
75.49
70.79
69.33
46.21
36.33
30.35
29.54
23.78
21.26
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
36.17
34.68
32.54
27.98
21.13
17.58
14.50
10.99
11.07
Sundry Debtors
21.01
16.36
18.10
11.86
9.24
7.77
6.34
5.92
6.41
Cash & Bank
4.86
6.81
5.45
1.86
2.04
1.24
4.30
3.56
0.36
Other Current Assets
13.45
5.63
0.12
0.10
3.92
3.75
4.40
3.32
3.41
Short Term Loans & Adv.
8.74
7.31
13.12
4.41
3.79
3.59
2.83
1.16
1.30
Net Current Assets
47.95
46.81
39.55
23.77
19.36
18.26
17.29
11.12
10.78
Total Assets
141.70
115.13
111.22
78.05
65.93
57.89
52.18
40.05
33.51

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
21.18
22.04
19.08
6.12
5.47
1.90
0.13
4.79
PBT
28.12
28.97
42.71
10.40
5.54
4.10
3.35
2.65
Adjustment
3.69
3.52
4.16
4.40
4.21
3.47
2.29
1.77
Changes in Working Capital
-3.13
-3.33
-16.90
-6.50
-3.09
-4.60
-4.50
1.16
Cash after chg. in Working capital
28.68
29.16
29.97
8.30
6.66
2.97
1.14
5.58
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-7.50
-7.12
-10.88
-2.19
-1.20
-1.08
-1.01
-0.79
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-20.73
-16.44
-4.86
-2.21
-4.11
-5.57
-8.39
-4.96
Net Fixed Assets
-13.15
-13.64
-4.17
-1.08
-1.50
-4.90
-6.24
Net Investments
-7.56
-2.76
0.00
0.00
0.00
0.00
0.00
Others
-0.02
-0.04
-0.69
-1.13
-2.61
-0.67
-2.15
Cash from Financing Activity
-2.40
-4.10
-10.60
-3.95
-0.22
0.23
8.87
2.01
Net Cash Inflow / Outflow
-1.95
1.51
3.62
-0.04
1.14
-3.44
0.62
1.85
Opening Cash & Equivalents
6.81
5.31
1.83
1.87
0.74
4.18
3.56
1.71
Closing Cash & Equivalent
4.86
6.81
5.45
1.83
1.87
0.74
4.18
3.56

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
133.00
104.36
83.21
47.42
38.93
31.46
29.72
27.81
26.46
ROA
16.37%
19.16%
33.50%
10.89%
6.32%
4.85%
4.73%
4.81%
4.87%
ROE
21.44%
27.98%
58.74%
21.97%
13.84%
11.27%
9.80%
8.42%
7.97%
ROCE
27.40%
33.74%
60.80%
21.45%
14.88%
13.59%
12.32%
12.06%
12.21%
Fixed Asset Turnover
2.84
2.62
3.29
2.04
2.21
2.79
2.81
2.88
2.59
Receivable days
47.36
50.91
38.45
48.49
47.85
44.28
42.44
46.03
55.19
Inventory Days
89.79
99.29
77.64
112.82
108.86
100.62
88.20
82.32
95.26
Payable days
25.39
24.97
23.89
29.07
10.07
9.45
11.72
13.79
13.90
Cash Conversion Cycle
111.76
125.23
92.20
132.24
146.63
135.44
118.91
114.56
136.54
Total Debt/Equity
0.06
0.09
0.21
0.61
0.74
1.06
0.98
0.53
0.38
Interest Cover
38.69
34.22
25.72
5.43
3.37
2.71
3.26
3.57
3.47

Annual Reports:

FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Titan Biotech to acquire stake in Titan Media
    12th Feb 2024, 17:14 PM

    The company is all set to acquire equity shares equivalent to voting rights of 64.58% of the total issued and paid up share capital of the Investee Company

    Read More
  • Titan Bio-Tech - Quarterly Results
    12th Feb 2024, 15:44 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.